Form 4: CVRx Inc. Executive John Robert Allen Reports Stock Option Grant

John Robert Allen, Chief Revenue Officer of CVRx, Inc., reports the acquisition of stock options.

Summary

• On June 27, 2024, John Robert Allen, Chief Revenue Officer of CVRx, Inc., acquired stock options for 122,192 shares.
• The exercise price of the options is $11.70.
• The options vest as to 25% of the shares on June 27, 2025, and then 1/48th of the shares each month thereafter.
• The expiration date for the options is June 26, 2034.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is slightly positive as it indicates alignment of management with shareholder interests through equity ownership.

Positives

• The grant of stock options to the Chief Revenue Officer aligns his interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

Stock option grants are a common form of executive compensation in the technology and healthcare industries, aligning management's interests with shareholder value creation.

Comparison to Industry Standards

• Stock option grants are a typical component of executive compensation packages in publicly traded companies, particularly in growth-oriented sectors like medical technology.
• Vesting schedules, such as the one described (25% after one year, then monthly), are standard practice to incentivize long-term performance.
• The size of the grant (122,192 shares) would need to be compared to grants given to executives in comparable roles at similar-sized medical device companies to assess its relative magnitude.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it aligns the executive's interests with the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates